A case of imiquimod-induced alopecia.
Imiquimod cream 5% is an immune modifier approved for the treatment of genital warts, actinic keratosis, and basal cell carcinoma. This case report presents an isolated case of telogen effluvium after 6 weeks of imiquimod treatment for an actinic keratosis on the scalp. Based on this case presentation, telogen effluvium is a potential rare side effect from imiquimod treatment.
Conde
Jennifer
J
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.
Davis
Katherine
K
Ntuen
Edidiong
E
Balmer
Nicole
N
Jones
Daniel
D
McMichael
Amy
A
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000505:Alopecia / Q000139:chemically induced*; D000634:Aminoquinolines / Q000009:adverse effects*; D001706:Biopsy; D005260:Female; D006801:Humans; D000077271:Imiquimod; D055623:Keratosis, Actinic / Q000188:drug therapy; D008875:Middle Aged; D009824:Ointments
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D009824:Ointments; D000077271:Imiquimod